Publications

Chronic obstructive pulmonary disease and risk of incident cardiovascular disease, chronic kidney disease, and death: Systematic review and meta-analysis

28 July 2026

eClinicalmedicine

Tobin Joseph, Chenyi Gao, Ramesh Nadarajah, Riyad Al-Lehebi, Luis Alves, David D Berg, Amy Couper, Indranil Datta, Loay Eleyan, Mohammad Haris, Nathanial Hawkins, John R Hurst, Christine R. Jenkins, Alan Kaplan, Janwillem W.H. Kocks, Konstantinos Kostikas, Carolyn SP Lam, Therese Laperre, Fernando Martinez, Alexandra Mircescu, Maria Felicia Montero Arias, Umbreen Nadeem, Long Nguyen, Kate Wignall, Rachel Pullen, Keerthenan Raveendra, Chin Kook Rhee, Naveed Sattar, Daiana Stolz, Yongchang Sun, Gary Tse, Tonya Winders, David B Price, Mohit Bhutani, Jianhua Wu, Chris P Gale

Full Text

Pub Med

Association of easier biologic access with remission and other clinical outcomes in severe asthma: a global real-world study (GLEAM II)

28 July 2026

J Allergy Asthma

Susanne Hansen, Ming-Ju Tsai, Trung N. Tran, John D. Blakey, Benjamin Emmanuel, Shawn D. Aaron, Yahya Habis, Valeria Perugini, Alan Altraja, Rohit K. Katial, Luis Perez-de-Llano, Paul E. Pfeffer, Nikolaos G. Papadopoulos, John Townend, Ghislaine Scelo, Aaron Beastall, Lakmini Bulathsinhala, John Busby, Andrew W. Lindsley, Wendy C. Moore, Reynold A. Panettieri Jr., Giorgio Walter Canonica, Enrico Heffler, Cristina Cardini, Giuseppe Guida, Celeste M. Porsbjerg, Anne-Sofie Bjerrum, Anna von Bülow, Ole Hilberg, Kjell Erik Julius Håkansson, Marianne Baastrup Søndergaard, Charlotte Suppli Ulrik, Eileen Wang, Michael E. Wechsler, Nicholas Chapman, Flavia Hoyte, Kanao Otsu, Liam G. Heaney, David J. Jackson, Pujan H. Patel, Dermot Ryan, Celine Bergeron, Shelley Abercromby, Mohit Bhutani, Kenneth R. Chapman, Andréanne Côté, Beth E. Davis, Delbert R. Dorscheid, Leiana Hoshyari, Brianne Philipenko, Hana Serajeddini, Florence Schleich, Renaud Louis, Piotr Kuna, Borja G. Cosio, Désirée Larenas-Linnemann, Carlos A. Torres-Duque, María José Fernández-Sánchez, Elizabeth Garcia, Fabio Bolívar-Grimaldos, Libardo Jiménez-Maldonado, Diana Jimena Cano-Rosales, Ivan Solarte, Riyad Al-Lehebi, Adeeb A. Bulkhi, Mona Al-Ahmad, Takashi Iwanaga, Soichiro Hozawa, Hisako Matsumoto, Tatsuya Nagano, Tomoko Tajiri, Bernt Bøgvald Aarli, Diahn-Warng Perng, Yi-Han Hsiao, Pin-Kuei Fu, Chau-Chyun Sheu, Konstantinos Kostikas, Mina Gaga, Athena Gogali, Maria Kallieri, Stelios Loukides, Michael Makris, Maria Dimosthenis Ntakoula, Andriana I. Papaioannou, Giannis Paraskevopoulos, Fotios Psarros, Bassam Mahboub, Laila Salameh, Mariko Siyue Koh, Mei Fong Liew, Pee Hwee Pang, Tze Lee Tan, Tunn Ren Tay, Paulo Márcio Pitrez, Chin Kook Rhee, Njira Lugogo, Arjun Mohan, João A. Fonseca, Ana Alves da Silva, Cláudia Chaves Loureiro, Hadassa Cristhina de Azevedo Soares dos Santos, Jorge Máspero, Ledit R. F. Ardusso, María Eugenia Franchi, Martin Sivori, Ana María Stok, Anahí Yáñez, George C. Christoff, Todor A. Popov, Patrick D. Mitchell, Sundeep Salvi, Richard W. Costello, Eve Denton, Mark Hew, Christine Jenkins, David Langton, Peter G. Middleton, Matthew J. Peters, Lauri Lehtimäki, Arnaud Bourdin, Camille Taillé, Christian Taube, Zsuzsanna Csoma, Dóra Lúdvíksdóttir, Job F.M. van Boven, James Fingleton, Leif Bjermer, Helena Emery, Graham Lough, Roy Alton Pleasants, Diego J. Maselli, Christopher S. Ambrose, Cathy Emmas, Andrew N. Menzies-Gow, Victoria Carter, Nevaashni Eleangovan, Ruth B. Murray, Chris A. Price, Mohsen Sadatsafavi, David B. Price

Full Text

Pub Med

Modifiable high-risk COPD identification and practical application of the CONQUEST quality improvement program in the United Kingdom

28 July 2026

PHCRD

David MG Halpin, James Gatenby, Katherine Hickman, John R Hurst, Amy Couper, Andrew P Dickens, Alexander Evans, Alejandro Adan Coronado, Rachel Pullen, Luis Alves, Mona Bafadhel, Victoria Carter, Michael Crooks, Marc Miravitlles, Tamsin Morris, Hana Muellerova, Mukesh Singh, Jennifer K Quint, Dave Singh, Tom Wilkinson, Tonya Winders, David Price

Full Text

Pub Med

Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD (GLEAM I)

28 July 2026

CHEST

Giorgio Walter Canonica, George C. Christoff, Ming-Ju Tsai, Trung N. Tran, John Townend, Ghislaine Scelo, Aaron Beastall, Lakmini Bulathsinhala, John Busby, Andrew W. Lindsley, Wendy C. Moore, Reynold A. Panettieri Jr., Enrico Heffler, Cristina Cardini, Giuseppe Guida, Eileen Wang, Michael E. Wechsler, Nicholas Chapman, Flavia Hoyte, Rohit K. Katial, Kanao Otsu, Celeste M. Porsbjerg, Anne-Sofie Bjerrum, Anna von Bülow, Susanne Hansen, Ole Hilberg, Kjell Erik Julius Håkansson, Marianne Baastrup Søndergaard, Charlotte Suppli Ulrik, Liam G. Heaney, David J. Jackson, Pujan H. Patel, Paul E. Pfeffer, Dermot Ryan, Piotr Kuna, Celine Bergeron, Shawn D. Aaron, Shelley Abercromby, Mohit Bhutani, Kenneth R. Chapman, Andréanne Côté, Beth E. Davis, Delbert R. Dorscheid, Leiana Hoshyari, Brianne Philipenko, Mohsen Sadatsafavi, Hana Serajeddini, Désirée Larenas-Linnemann, Borja G. Cosio, Luis Perez-de-Llano, Carlos A. Torres-Duque, María José Fernández-Sánchez, Elizabeth Garcia, Fabio Bolívar-Grimaldos, Libardo Jiménez-Maldonado, Diana Jimena Cano-Rosales, Ivan Solarte, Florence Schleich, Renaud Louis, Riyad Al-Lehebi, Adeeb A. Bulkhi, Yahya Habis, Mona Al-Ahmad, Bassam Mahboub, Laila Salameh, Paulo Márcio Pitrez, Takashi Iwanaga, Soichiro Hozawa, Hisako Matsumoto, Tatsuya Nagano, Tomoko Tajiri, João A. Fonseca, Ana Alves da Silva, Cláudia Chaves Loureiro, Hadassa Cristhina de Azevedo Soares dos Santos, Nikolaos G. Papadopoulos, Konstantinos Kostikas, Mina Gaga, Athena Gogali, Maria Kallieri, Stelios Loukides, Michael Makris, Maria Ntakoula, Andriana I. Papaioannou, Giannis Paraskevopoulos, Fotios Psarros, Diahn-Warng Perng, Yi-Han Hsiao, Pin-Kuei Fu, Chau-Chyun Sheu, Bernt Bøgvald Aarli, Todor A. Popov, Mariko Siyue Koh, Mei Fong Liew, Pee Hwee Pang, Tze Lee Tan, Tunn Ren Tay, Chin Kook Rhee, Jorge Máspero, Ledit R. F. Ardusso, María Eugenia Franchi, Martin Sivori, Ana María Stok, Anahí Yáñez, Njira Lugogo, Arjun Mohan, Patrick D. Mitchell, Alan Altraja, Sundeep Salvi, Richard W. Costello, Eve Denton, Mark Hew, Christine Jenkins, David Langton, Peter G. Middleton, Matthew J. Peters, Lauri Lehtimäki, Arnaud Bourdin, Camille Taillé, Christian Taube, Zsuzsanna Csoma, Dóra Lúdvíksdóttir, Job F.M. van Boven, James Fingleton, Helena Emery, Graham Lough, Valeria Perugini, Leif Bjermer, Diego J. Maselli, Roy Alton Pleasants, Christopher S. Ambrose, Benjamin Emmanuel, Cathy Emmas, Andrew N. Menzies-Gow, Amit D. Parulekar, Victoria Carter, Nevaashni Eleangovan, Ruth B. Murray, Chris A. Price, John D. Blakey, David B. Price

Full Text

Pub Med

Prevalence of type 2 multimorbidities in COPD compared to asthma and relationship to blood eosinophilic counts

11 June 2026

ERJOR

David M. G. Halpin, Jaspreet Kaur, Heath Heatley, Freya Tyrer, Cono Ariti, Rachel Pullen, Shelly Pathak, Victoria Carter and David Price

Publications

Chronic obstructive pulmonary disease and risk of incident cardiovascular disease, chronic kidney disease, and death: Systematic review and meta-analysis

Association of easier biologic access with remission and other clinical outcomes in severe asthma: a global real-world study (GLEAM II)

Modifiable high-risk COPD identification and practical application of the CONQUEST quality improvement program in the United Kingdom

Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD (GLEAM I)

Prevalence of type 2 multimorbidities in COPD compared to asthma and relationship to blood eosinophilic counts

Geographical variability in severe asthma: comparison of patients’ characteristics between national, regional and international cohorts in ISAR

At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK (ARRISA-UK): national cluster randomised controlled trial

Projecting the 20-Year Economic Burden of Asthma and COPD Multimorbidity: Insights from Singapore for Integrated Chronic Care in Asia

Reply to Liu et al., Zhou et al., and Dong et al.

Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) model

Severe asthma patients’ characteristics in Mexico versus International Severe Asthma Registry (ISAR) Global

Lung Cancer in interstitial lung disease: a matched case-control and cohort analysis

Characterising Patient Pathways prior to the Diagnosis of Interstitial Lung Disease

Development and internal validation of a prediction model for major cardiovascular and respiratory events in chronic obstructive pulmonary disease: nationwide primary care electronic medical records cohort study

Community-based prediction models of cardiovascular events, acute exacerbations and all-cause mortality in individuals with chronic obstructive pulmonary disease: systematic review and meta-analysis on behalf of the International Cardiovascular and Respiratory Alliance

Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registries

Healthcare Costs and Trends of Multimorbidity in COPD Patients: A Population-Based Study in Singapore

The potential impact of GLP-1 receptor agonists on exacerbation risk in patients with COPD and type 2 diabetes: A real-world population-based observational study

Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World Data

Design and implementation of data collection and linkage of electronic health records in a large UK cluster-randomised trial of asthma management (ARRISA-UK)

Company

Observational and Pragmatic Research Institute (registered in Singapore)